Drawing for NUMEN

USPTO serial 99470581

NUMEN

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
REID, CAILE MAUREEN
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUMEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or medical research use; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; biochemicals for in vitro and in vivo scientific use; fluorescent dye for scientific or research use; biochemical reagents used for non-medical purposes, namely, for detecting and analyzing molecules in biological sample matrices; buffer solutions for use in analytical chemistry; diagnostic reagents for use with enzyme linked immunosorbent assays (ELISA) to measure various analytes in biofluids; reagents in kit form for scientific purposes, namely, conducting enzyme linked immunosorbent assays (ELISA) other than for medical or veterinary purposesACTIVE—
005Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; medical diagnostic reagents and assays for testing of body fluids; diagnostic reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; biochemical reagents for medical purposesACTIVE—
009Downloadable computer software using artificial intelligence and machine learning for use in diagnostic medical testing; downloadable computer software using artificial intelligence and machine learning for running and analyzing clinical diagnostics; downloadable computer software for delivering laboratory results; downloadable computer software that allows patients to access their laboratory results and share their results with medical and healthcare providers; downloadable computer software using artificial intelligence and machine learning for users to manage their health and healthcare; downloadable computer software for analyzing data compiled by medical testing apparatus and instruments; downloadable computer software for remote monitoring, maintaining, and troubleshooting of medical testing apparatus and instruments; downloadable computer software using artificial intelligence and machine learning for reviewing the status of medical testing apparatus and instruments; none of the foregoing for cloud computing infrastructure management, cloud platform services, cloud application deployment, enterprise data storage, enterprise data archiving, enterprise data processing, enterprise data visualization, or IT systems administrationACTIVE—
010Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, genitourinary tract diseases, inflammatory disorders and diseases, metabolic disorders and diseases, fertility, and pregnancy; point-of-care medical device, namely, automated molecular diagnostic testing device for detecting disease; medical diagnostic apparatus, namely, molecular diagnostic testing apparatus for detecting disease; portable diagnostic medical testing instrument for use in point-of-case diagnostics for use in disease detection; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, genitourinary tract diseases, inflammatory disorders and diseases, metabolic disorders and diseases, fertility, and pregnancy detectionACTIVE—
042Providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for use in diagnostic medical testing; providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for running and analyzing clinical diagnostics; providing temporary use of on-line non-downloadable computer software for delivering laboratory results; providing medical testing services and information in the form of medical research, in the field of disease detection; providing temporary use of non-downloadable cloud-based secure database software that allows patients to access their laboratory results and share their results with medical and healthcare providers; scientific and medical research in the fields of disease detection, biofluid testing, wellness, fertility, pregnancy, and oncology; providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for users to manage their health and healthcare; providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for analyzing data compiled by medical testing apparatus and instruments; providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for remote monitoring, maintaining, and troubleshooting of medical testing apparatus and instruments; providing temporary use of on-line non-downloadable computer software using artificial intelligence and machine learning for reviewing the status of medical testing apparatus and instruments; none of the foregoing relating to cloud infrastructure management, cloud platform services, cloud application deployment, enterprise data storage, enterprise data processing, enterprise data archiving, enterprise data visualization, or the administration or management of public or private cloud computing systemsACTIVE—
044Medical testing for diagnostic or treatment purposes in the fields of oncology, genitourinary tract diseases, inflammatory disorders and diseases, metabolic disorders and diseases, fertility, and pregnancy; medical diagnostic testing, monitoring and reporting services; medical testing, screening, and assessment being evaluation services of diagnostics in the fields of cancer, genitourinary tract diseases, inflammatory disorders and diseases, metabolic disorders and diseases, fertility, and pregnancy detection provided via a cloud-based website portal; testing for medical diagnostic purposes in the field of disease detectionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 9, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 30, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance